Business General News Technology

Global Anatomic Pathology Market was Valued at USD 15.59 Billion in 2016 and is Projected to Reach USD 25.61 Billion By 2025

The global Anatomic Pathology Market was valued at USD 15.59 billion in 2016 and is projected to reach USD 25.61 billion by 2025, growing at a CAGR of 5.67% from 2017 to 2025.

Anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. With increasing prevalence of diseases and infections, major changes in lifestyle and pressure on Patient centric healthcare are major factors for the market to grow rapidly.

Sample Infographics:

Market Dynamics:
1. Market Drivers
1.1 Increasing cases of cancer
1.2 Growing geriatric population
1.3 Growing Healthcare investments

2. Market Restraints
2.1 Stringent Govt. Regulations like tax implementation n U.S.

Market Segmentation:
1. Global Anatomic Pathology Market, by Application:
1.1 Diseases Diagnosis
1.2 Drug Discovery & Development
1.3 Other Applications

2. Global Anatomic Pathology Market, by Products & Services:
2.1 Instruments
2.1.1 Tissue Processing Systems
2.1.2 Slide Staining Systems
2.1.3 Microtomes
2.1.4 Other Instruments
2.2 Consumables
2.2.1 Antibodies & Reagents
2.2.2 Kits
2.2.3 Probes
2.2.4 Other Consumables
2.3 Services
2.3.1 Cytopathology
2.3.2 Histopathology
2.3.3 Other Services

3. Global Anatomic Pathology Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. F. Hoffmann-La Roche AG.
2. Danaher Corporation
3. Thermo Fisher Scientific, Inc.
4. Laboratory Corporation of America Holdings
5. Quest Diagnostics Incorporated
6. Agilent Technologies, Inc.
7. Sakura Finetechnical Co., Ltd.
8. Biogenex Laboratories
9. Bio SB
10. Neogenomics Laboratories, Inc.

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Research study on the Anatomic Pathology Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.

The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

Quick Contact!

To get in touch with The for any queries or feedback, please send an email to And, we will get back to you shortly.

Get the News Directly in Your Mailbox!

Enter your email address:

Delivered by FeedBurner

Recent News